Cargando…

Next-generation sequencing and PCR technologies in monitoring the hospital microbiome and its drug resistance

The hospital environment significantly contributes to the onset of healthcare-associated infections (HAIs), which represent one of the most frequent complications occurring in healthcare facilities worldwide. Moreover, the increased antimicrobial resistance (AMR) characterizing HAI-associated microb...

Descripción completa

Detalles Bibliográficos
Autores principales: Cason, Carolina, D’Accolti, Maria, Soffritti, Irene, Mazzacane, Sante, Comar, Manola, Caselli, Elisabetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370071/
https://www.ncbi.nlm.nih.gov/pubmed/35966671
http://dx.doi.org/10.3389/fmicb.2022.969863
_version_ 1784766676532723712
author Cason, Carolina
D’Accolti, Maria
Soffritti, Irene
Mazzacane, Sante
Comar, Manola
Caselli, Elisabetta
author_facet Cason, Carolina
D’Accolti, Maria
Soffritti, Irene
Mazzacane, Sante
Comar, Manola
Caselli, Elisabetta
author_sort Cason, Carolina
collection PubMed
description The hospital environment significantly contributes to the onset of healthcare-associated infections (HAIs), which represent one of the most frequent complications occurring in healthcare facilities worldwide. Moreover, the increased antimicrobial resistance (AMR) characterizing HAI-associated microbes is one of the human health’s main concerns, requiring the characterization of the contaminating microbial population in the hospital environment. The monitoring of surface microbiota in hospitals is generally addressed by microbial cultural isolation. However, this has some important limitations mainly relating to the inability to define the whole drug-resistance profile of the contaminating microbiota and to the long time period required to obtain the results. Hence, there is an urgent need to implement environmental surveillance systems using more effective methods. Molecular approaches, including next-generation sequencing and PCR assays, may be useful and effective tools to monitor microbial contamination, especially the growing AMR of HAI-associated pathogens. Herein, we summarize the results of our recent studies using culture-based and molecular analyses in 12 hospitals for adults and children over a 5-year period, highlighting the advantages and disadvantages of the techniques used.
format Online
Article
Text
id pubmed-9370071
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93700712022-08-12 Next-generation sequencing and PCR technologies in monitoring the hospital microbiome and its drug resistance Cason, Carolina D’Accolti, Maria Soffritti, Irene Mazzacane, Sante Comar, Manola Caselli, Elisabetta Front Microbiol Microbiology The hospital environment significantly contributes to the onset of healthcare-associated infections (HAIs), which represent one of the most frequent complications occurring in healthcare facilities worldwide. Moreover, the increased antimicrobial resistance (AMR) characterizing HAI-associated microbes is one of the human health’s main concerns, requiring the characterization of the contaminating microbial population in the hospital environment. The monitoring of surface microbiota in hospitals is generally addressed by microbial cultural isolation. However, this has some important limitations mainly relating to the inability to define the whole drug-resistance profile of the contaminating microbiota and to the long time period required to obtain the results. Hence, there is an urgent need to implement environmental surveillance systems using more effective methods. Molecular approaches, including next-generation sequencing and PCR assays, may be useful and effective tools to monitor microbial contamination, especially the growing AMR of HAI-associated pathogens. Herein, we summarize the results of our recent studies using culture-based and molecular analyses in 12 hospitals for adults and children over a 5-year period, highlighting the advantages and disadvantages of the techniques used. Frontiers Media S.A. 2022-07-28 /pmc/articles/PMC9370071/ /pubmed/35966671 http://dx.doi.org/10.3389/fmicb.2022.969863 Text en Copyright © 2022 Cason, D’Accolti, Soffritti, Mazzacane, Comar and Caselli. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Cason, Carolina
D’Accolti, Maria
Soffritti, Irene
Mazzacane, Sante
Comar, Manola
Caselli, Elisabetta
Next-generation sequencing and PCR technologies in monitoring the hospital microbiome and its drug resistance
title Next-generation sequencing and PCR technologies in monitoring the hospital microbiome and its drug resistance
title_full Next-generation sequencing and PCR technologies in monitoring the hospital microbiome and its drug resistance
title_fullStr Next-generation sequencing and PCR technologies in monitoring the hospital microbiome and its drug resistance
title_full_unstemmed Next-generation sequencing and PCR technologies in monitoring the hospital microbiome and its drug resistance
title_short Next-generation sequencing and PCR technologies in monitoring the hospital microbiome and its drug resistance
title_sort next-generation sequencing and pcr technologies in monitoring the hospital microbiome and its drug resistance
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370071/
https://www.ncbi.nlm.nih.gov/pubmed/35966671
http://dx.doi.org/10.3389/fmicb.2022.969863
work_keys_str_mv AT casoncarolina nextgenerationsequencingandpcrtechnologiesinmonitoringthehospitalmicrobiomeanditsdrugresistance
AT daccoltimaria nextgenerationsequencingandpcrtechnologiesinmonitoringthehospitalmicrobiomeanditsdrugresistance
AT soffrittiirene nextgenerationsequencingandpcrtechnologiesinmonitoringthehospitalmicrobiomeanditsdrugresistance
AT mazzacanesante nextgenerationsequencingandpcrtechnologiesinmonitoringthehospitalmicrobiomeanditsdrugresistance
AT comarmanola nextgenerationsequencingandpcrtechnologiesinmonitoringthehospitalmicrobiomeanditsdrugresistance
AT casellielisabetta nextgenerationsequencingandpcrtechnologiesinmonitoringthehospitalmicrobiomeanditsdrugresistance